Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of DITPA in Patients With NYHA Class III and IV Congestive Heart Failure Who Have Low Serum T3 Levels

NCT00103519 is registered in ClinicalTrials.gov with Titan Pharmaceuticals as lead sponsor.

NCT NCT00103519
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00103519 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of DITPA in Patients With NYHA Class III and IV Congestive Heart Failure Who Have Low Serum T3 Levels
Lead sponsor
Titan Pharmaceuticals
Phase
Phase 2
Overall status
Terminated
Start date
December 31, 2004
Completion date
December 31, 2006
Enrollment
86 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, congestive